$PVCT Undrvalued Performance Review: To r
Post# of 107
(Total Views: 300)
Posted On: 02/07/2017 11:49:33 AM
$PVCT Undrvalued
Performance Review:
To review the PVCT previous performance, look at its past history, which highlighted below:
During last 5 trades the stock sticks almost 4.37%.
During last one month it showed the change of 1.18%.
During last 3 month it remained at -71.80%.
Along with these its year to date performance is standing at -12.24%.
Important Technical Indicators:
ATR value of company was 0.00. Relative Strength Index (RSI) was 52.56. Developed J. Welles Wilder, the Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
The stock volatility for week was 6.94% while for month was 9.71%.The stock, as of last close, traded 56.36% to its 52 week low and was changed -96.80% from its 52 week high. PVCT’s value Change from Open was at -4.44% with a Gap of 5.88%.
Analysts Mean Rating:
Analysts’ mean recommendation for Provectus Biopharmaceuticals, Inc.’s (PVCT) stands at 2.00. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
Performance Review:
To review the PVCT previous performance, look at its past history, which highlighted below:
During last 5 trades the stock sticks almost 4.37%.
During last one month it showed the change of 1.18%.
During last 3 month it remained at -71.80%.
Along with these its year to date performance is standing at -12.24%.
Important Technical Indicators:
ATR value of company was 0.00. Relative Strength Index (RSI) was 52.56. Developed J. Welles Wilder, the Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
The stock volatility for week was 6.94% while for month was 9.71%.The stock, as of last close, traded 56.36% to its 52 week low and was changed -96.80% from its 52 week high. PVCT’s value Change from Open was at -4.44% with a Gap of 5.88%.
Analysts Mean Rating:
Analysts’ mean recommendation for Provectus Biopharmaceuticals, Inc.’s (PVCT) stands at 2.00. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
(0)
(0)Provectus Biopharmaceuticals Inc. (PVCT) Stock Research Links
Here We Go!!!!
Scroll down for more posts ▼